Blog

New England Journal of Medicine Publishes Pivotal Phase III Data for CSL Behring’s Subcutaneous C1-Esterase … – Yahoo Finance

Posted: Wednesday, April 05, 2017

- Median reduction in hereditary angioedema (HAE) attack rate relative to placebo was 95% at the highest dose studied – Data show up to 40% of HAE patients were free from attacks throughout the study  – In the clinical study, CSL830 met the primary endpoint for preventing HAE attacks KING OF PRUSSIA, Pa. , April 4, 2017 /CNW/ — Global biotherapeutics leader CSL Behring today announced that results were published…

Tobacco use down by ‘paltry’ 2.55% in 10 yrs: Lancet – Daily News & Analysis

Posted: Wednesday, April 05, 2017

Global efforts to control use of tobacco have led to a decline in prevalence of smoking, according to the latest paper published in international medical journal The Lancet. The mean smoking prevalence across the world, has decreased by “a paltry” 2.55 per cent. “While in 2005, the prevalence was 24.73 per cent, it has reduced to 22.18 per cent in 2015,” states the paper. Smoking prevalence means number of persons…

Diet change may help save water: Lancet – The Asian Age

Posted: Tuesday, April 04, 2017

New Delhi: Reducing the consumption of “poultry” and “wheat” and increasing the consumption of fruits and vegetables could significantly reduce groundwater use in India and help the country meet the challenge of feeding 1.64 billion people by 2050, said a recent study. As per the study published in the first issue of Lancet Planetary Health, modifying diets include reducing the consumption of wheat and poultry, increasing the consumption…

New England Journal of Medicine Publishes Pivotal Phase III Data for CSL Behring’s Subcutaneous C1-Esterase … – Yahoo Finance

Posted: Tuesday, April 04, 2017

- Median reduction in hereditary angioedema (HAE) attack rate relative to placebo was 95% at the highest dose studied – Data show up to 40% of HAE patients were free from attacks throughout the study  – In the clinical study, CSL830 met the primary endpoint for preventing HAE attacks KING OF PRUSSIA, Pa. , April 4, 2017 /CNW/ — Global biotherapeutics leader CSL Behring today announced that results were published…

New England Journal of Medicine Publishes Pivotal Phase III Data for CSL Behring’s Subcutaneous C1-Esterase … – Yahoo Finance

Posted: Tuesday, April 04, 2017

- Median reduction in hereditary angioedema (HAE) attack rate relative to placebo was 95% at the highest dose studied – Data show up to 40% of HAE patients were free from attacks throughout the study  – In the clinical study, CSL830 met the primary endpoint for preventing HAE attacks KING OF PRUSSIA, Pa. , April 4, 2017 /CNW/ — Global biotherapeutics leader CSL Behring today announced that results were published…

Drug-resistant TB cases rising in India: Lancet – Hindustan Times

Posted: Sunday, March 26, 2017

Incidences of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) — associated with high mortality rate — is on the rise in India, while threatening to derail the progress achieved in controlling the disease, researchers say. Nearly one in five cases of TB are now resistant to at least one major anti-TB drug and approximately 5% of all cases of TB are classed as MDR (resistant to two essential first-line…

New TB Drugs Risk Becoming Ineffective If Misused, Lancet Report Warns – Kaiser Family Foundation

Posted: Saturday, March 25, 2017

New TB Drugs Risk Becoming Ineffective If Misused, Lancet Report Warns Mar 24, 2017 CIDRAP News: Report warns of rise in drug-resistant tuberculosis “A new report warns that some of the incremental progress made in the global fight against tuberculosis (TB) could be lost with the emergence and spread of drug-resistant strains of the disease…” (Dall, 3/23). Humanosphere: Emerging epidemic of multidrug-resistant TB ‘threatens decades of progress’ “…According to the report…

Drug-resistant TB cases rising in India: Lancet – The Siasat Daily

Posted: Friday, March 24, 2017

Mumbai: Incidences of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) — associated with high mortality rate — is on the rise in India, while threatening to derail the progress achieved in controlling the disease, researchers say. Nearly one in five cases of TB are now resistant to at least one major anti-TB drug and approximately five per cent of all cases of TB are classed as…

Tobacco Control Treaty Cut Global Smoking Rates By 2.5%: Lancet … – News18

Posted: Friday, March 24, 2017

WHO’s tobacco control treaty, which came into effect in 2005, has achieved a 2.5 per cent reduction in global smoking rate, according to a study published in The Lancet Public Health. According to WHO, tobacco use causes nearly six million deaths a year globally. The treaty WHO Framework Convention on Tobacco Control (WHO-FCTC) obligates the 180 countries committed to it to implement strong evidence-based policies, including five key…

Drug-Resistant TB Threatens Global Control Efforts, Researchers Warn In Lancet Report – Kaiser Family Foundation

Posted: Thursday, March 23, 2017

Drug-Resistant TB Threatens Global Control Efforts, Researchers Warn In Lancet Report Mar 23, 2017 The Guardian: Decades of TB progress threatened by drug-resistant bacteria, warn experts “The rise of multi-drug resistant bacteria threatens to overturn decades of progress on tuberculosis (TB), experts are warning. Multi-drug resistant (MDR) and extensively drug-resistant (XDR) strains of TB are causing increasing concern, says a new report in the Lancet Respiratory Medicine journal. Migration and travel…

Tobacco Control Treaty Cut Global Smoking Rates By 2.5%: Lancet – News18

Posted: Thursday, March 23, 2017

WHO’s tobacco control treaty, which came into effect in 2005, has achieved a 2.5 per cent reduction in global smoking rate, according to a study published in The Lancet Public Health. According to WHO, tobacco use causes nearly six million deaths a year globally. The treaty WHO Framework Convention on Tobacco Control (WHO-FCTC) obligates the 180 countries committed to it to implement strong evidence-based policies, including five key…

Tobacco control treaty cut global smoking rates by 2.5%: Lancet – Daily Pioneer

Posted: Thursday, March 23, 2017

Nabard launches drive for 10 parched districts 23 Mar 2017 | PNS | BHUBANESWAR The Nabard launched a national level water campaign in Odisha here on Wednesday, marking the World Water day. Nabard CGM Dr KC Panigrahi kicked off the drive, which was attended by Indian Institute of Water Management, Bhubaneswar, Director Dr SK Ambast and representatives of the State Government, the State Level Bankers’ Committee…

Tobacco control treaty cut global smoking rates by 2.5%: Lancet – Yahoo News

Posted: Wednesday, March 22, 2017

Toronto, March 22 (IANS) WHO’s tobacco control treaty, which came into effect in 2005, has achieved a 2.5 per cent reduction in global smoking rate, according to a study published in The Lancet Public Health. According to WHO, tobacco use causes nearly six million deaths a year globally. The treaty — WHO Framework Convention on Tobacco Control (WHO-FCTC) — obligates the 180 countries committed to it to implement strong evidence-based…

Tobacco control treaty cut global smoking rates by 2.5%: Lancet – Business Standard

Posted: Wednesday, March 22, 2017

WHO’s tobacco control treaty, which came into effect in 2005, has achieved a 2.5 per cent reduction in global smoking rate, according to a study published in The Lancet Public Health. According to WHO, tobacco use causes nearly six million deaths a year globally. The treaty — WHO Framework Convention on Tobacco Control (WHO-FCTC) — obligates the 180 countries committed to it to implement strong evidence-based policies, including…